This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 21:29, 20 October 2011 (Updating {{drugbox}} (changes to verified fields - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot|bug...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 21:29, 20 October 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to verified fields - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot|bug...)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundCombination of | |
---|---|
Clofexamide | ? Class |
Phenylbutazone | Non-steroidal anti-inflammatory drug |
Clinical data | |
Routes of administration | Oral, rectal, topical |
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.037.681 |
Chemical and physical data | |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Clofezone is a drug used for joint and muscular pain. It is a combination of clofexamide and phenylbutazone.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
Topical products for joint and muscular pain (M02) | |||||||
---|---|---|---|---|---|---|---|
Anti-inflammatory preparations, non-steroids |
| ||||||
Capsaicin derivatives | |||||||
Other |
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |